Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro

Stem Cell Research and Therapy

Volumn 5, Issue 1, 2014, Pages

  Schnabel, Lauren V ^a   Pezzanite, Lynn M ^b   Antczak, Douglas F ^b   Felippe, M Julia Bevilaqua ^b   Fortier, Lisa A ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD45RB ANTIGEN; HERMES ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT GAMMA INTERFERON; THY 1 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; CD3+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; HAPLOTYPE; HOMOZYGOTE; HORSE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPHENOTYPING; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STROMA CELL; MIXED LYMPHOCYTE REACTION; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL CULTURE; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE; GENETICS; IMMUNOLOGY;

EQUIDAE;

ANIMALS; CELLS, CULTURED; GENES, MHC CLASS II; HORSES; IMMUNOPHENOTYPING; INTERFERON-GAMMA; LEUKOCYTES; MESENCHYMAL STROMAL CELLS;

EID: 84892731743     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt402     Document Type: Article

References (41)

1. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T, Immunol Cell Biol 2013 91 40 51 10.1038/icb.2012.67 23207278
2. Immune plasticity of bone marrow-derived mesenchymal stromal cells. Stagg J, Galipeau J, Handb Exp Pharmacol 2007 180 45 66 10.1007/978-3-540-68976-8-3 17554504
3. Immune regulation by mesenchymal stem cells: two sides to the coin. Stagg J, Tissue Antigens 2007 69 1 9 17212702 (Pubitemid 46025333)
4. Immunological aspects of allogeneic mesenchymal stem cell therapies. Griffin MD, Ritter T, Mahon BP, Hum Gene Ther 2010 21 1641 1655 10.1089/hum.2010.156 20718666
5. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J, Blood 2005 106 4057 4065 10.1182/blood-2005-03-1004 16118325 (Pubitemid 41775910)
6. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. Potian JA, Aviv H, Ponzio NM, Harrison JS, Rameshwar P, J Immunol 2003 171 3426 3434 14500637 (Pubitemid 37254543)
7. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Zangi L, Margalit R, Reich-Zeliger S, Bachar-Lustig E, Beilhack A, Negrin R, Reisner Y, Stem Cells 2009 27 2865 2874 10.1002/stem.217 19750539
8. Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Badillo AT, Beggs KJ, Javazon EH, Tebbets JC, Flake AW, Biol Blood Marrow Transplant 2007 13 412 422 10.1016/j.bbmt.2006.12. 447 17382248 (Pubitemid 46421896)
9. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE, Blood 2006 108 2114 2120 10.1182/blood-2005-11-011650 16690970 (Pubitemid 44395028)
10. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D, Arthritis Rheum 2002 46 3349 3360 10.1002/art.10696 12483742 (Pubitemid 35453547)
11. Making progress in the what, when and where of regenerative medicine for our equine patients. Fortier LA, Equine Vet J 2012 44 511 512 10.1111/j.2042-3306.2012.00628.x 22888773
12. Stem cells in veterinary medicine. Fortier LA, Travis AJ, Stem Cell Res Ther 2011 2 9 14 10.1186/scrt50 21371354
13. Clinical update on the use of mesenchymal stem cells in equine orthopaedics. Frisbie DD, Smith RK, Equine Vet J 2010 42 86 89 20121921
14. Cell-based therapies for equine joint disease. Frisbie DD, Stewart MC, Vet Clin North Am Equine Pract 2011 27 335 349 10.1016/j.cveq.2011.06.005 21872762
15. Therapeutic use of stem cells in horses: which type, how, and when? Schnabel LV, Fortier LA, McIlwraith CW, Nobert KM, Vet J 2013 197 570 577 10.1016/j.tvjl.2013.04.018 23778257
16. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries? De Schauwer C, Van de Walle GR, Van Soom A, Meyer E, Vet Q 2013 epub ahead of print
17. Defining the expression of marker genes in equine mesenchymal stromal cells. Guest DJ, Ousey JC, Smith MRW, Stem Cell Cloning Adv Appl 2008 1 1 9
18. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity. De Schauwer C, Meyer E, Van de Walle GR, Van Soom A, Theriogenology 2011 75 1431 1443 10.1016/j.theriogenology.2010.11.008 21196039
19. Comparative analysis of the immunomodulatory properties of equine adult-derived mesenchymal stem cells. Carrade DD, Lame MW, Kent MS, Clark KC, Walker NJ, Borjesson DL, Cell Med 2012 4 1 11 10.3727/215517912X647217 23152950
20. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study. Guest DJ, Smith MR, Allen WR, Equine Vet J 2008 40 178 181 10.2746/042516408X276942 18267891 (Pubitemid 351717168)
21. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. Schnabel LV, Lynch ME, van der Meulen MC, Yeager AE, Kornatowski MA, Nixon AJ, J Orthop Res 2009 27 1392 1398 10.1002/jor.20887 19350658
22. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK, Equine Vet J 2012 44 25 32 10.1111/j.2042-3306.2011.00363.x 21615465
23. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. Wilke MM, Nydam DV, Nixon AJ, J Orthop Res 2007 25 913 925 10.1002/jor.20382 17405160 (Pubitemid 47046438)
24. Ferris DJ, Frisbie DD, Kisiday JD, McIlwraith CW, Hague BA, Major MD, Schneider RK, Zubrod CJ, Kawcak CE, Goodrich LR, Vet Surg 2014 In press
25. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW, J Orthop Res 2009 27 1675 1680 10.1002/jor.20933 19544397
26. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects. McIlwraith CW, Frisbie DD, Rodkey WG, Kisiday JD, Werpy NM, Kawcak CE, Steadman JR, Arthroscopy 2011 27 1552 1561 10.1016/j.arthro.2011.06.002 21862278
27. Joint Report of the Fifth International Workshop on Lymphocyte Alloantigens of the Horse; Baton Rouge, Louisiana, 31 October to 1 November 1987. Lazary S, Antczak DF, Bailey E, Bell TK, Bernoco D, Byrns G, McClure JJ, Anim Genet 1988 19 447 456 2466424
28. Analysis of MHC class I genes across horse MHC haplotypes. Tallmadge RL, Campbell JA, Miller DC, Antczak DF, Immunogenetics 2010 62 159 172 10.1007/s00251-009-0420-9 20099063
29. Genomic characterization of MHC class I genes of the horse. Tallmadge RL, Lear TL, Antczak DF, Immunogenetics 2005 57 763 774 10.1007/s00251-005-0034-9 16220348 (Pubitemid 41598622)
30. Identification of equine major histocompatibility complex haplotypes using polymorphic microsatellites. Tseng CT, Miller D, Cassano J, Bailey E, Antczak DF, Anim Genet 2010 41 150 153
31. Inhibition of lymphocyte proliferation and activation: a mechanism used by equine invasive trophoblast to escape the maternal immune response. Flaminio MJ, Antczak DF, Placenta 2005 26 148 159 10.1016/j.placenta.2004.05.008 15708116 (Pubitemid 40247003)
32. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations. Radcliffe CH, Flaminio MJ, Fortier LA, Stem Cells Dev 2010 19 269 282 10.1089/scd.2009.0091 19604071
33. A comparison of three-dimensional culture systems to evaluate in vitro chondrogenesis of equine bone marrow-derived mesenchymal stem cells. Watts AE, Ackerman-Yost JC, Nixon AJ, Tissue Eng Part A 2013 19 2275 2283 10.1089/ten.tea.2012.0479 23725547
34. MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge. Chan WK, Lau AS, Li JC, Law HK, Lau YL, Chan GC, Exp Hematol 2008 36 1545 1555 10.1016/j.exphem.2008.06.008 18715686
35. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. Romieu-Mourez R, Francois M, Boivin MN, Stagg J, Galipeau J, J Immunol 2007 179 1549 1558 17641021
36. Cell therapy for tendon repair in horses: an experimental study. Crovace A, Lacitignola L, De Siena R, Rossi G, Francioso E, Vet Res Commun 2007 31 281 283 10.1007/s11259-007-0047-y 17682895 (Pubitemid 47244324)
37. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Crovace A, Lacitignola L, Rossi G, Francioso E, Vet Med Int 2010 2010 250978 20445779
38. Joint report of the Third International Workshop on Lymphocyte Alloantigens of the Horse, Kennett Square, Pennsylvania, 25-27 April 1984. Antczak DF, Bailey E, Barger B, Guerin G, Lazary S, McClure J, Mottironi VD, Symons R, Templeton J, Varewyck H, Anim Genet 1986 17 363 373 3826760
39. Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses. Delling U, Lindner K, Ribitsch I, Julke H, Brehm W, Can J Vet Res 2012 76 52 56 22754095
40. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I, Stem Cells 2004 22 675 682 10.1634/stemcells.22-5- 675 15342932 (Pubitemid 39172200)
41. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF, J Orthop Res 1997 15 546 557 10.1002/jor.1100150410 9379264 (Pubitemid 27433368)